Allergy Therapeutics(AGYTF)
$0.140.00 (0.00%)
AGYTF
Allergy Therapeutics financials statements
$0.14
At close:0.00 (0.00%)
Allergy Therapeutics (AGYTF) Income Statement
2 Followers
Allergy Therapeutics Income Statement
Last quarter (Q4 2026), Allergy Therapeutics's total revenue was £23.59M, an increase of 9.07% from the same quarter last year. In Q4, Allergy Therapeutics's net income was £-31.59M. See Allergy Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| £ 59.87M | £ 55.04M | £ 55.20M | £ 59.59M | £ 72.77M | |
| £ 24.78M | £ 25.13M | £ 29.74M | £ 32.69M | £ 48.95M | |
| £ 65.75M | £ 54.63M | £ 64.99M | £ 72.90M | £ 61.95M | |
| Depreciation and Amortization | £ 4.64M | £ 4.17M | £ 4.32M | £ 4.22M | £ 4.17M |
| £ -36.34M | £ -29.43M | £ -30.74M | £ -36.24M | £ -8.69M | |
| £ -40.98M | £ -29.50M | £ -35.26M | £ -34.85M | £ -13.00M | |
| £ -11.44M | £ -10.94M | £ -3.91M | £ -7.77M | £ -396.00K | |
| £ -52.41M | £ -40.44M | £ -39.17M | £ -42.62M | £ -13.40M | |
| £ -51.51M | £ -40.13M | £ -40.22M | £ -43.07M | £ -13.78M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.01 | £ -0.01 | £ -0.01 | £ -0.06 | £ -0.02 |
| Diluted EPS | £ -0.01 | £ -0.01 | £ -0.01 | £ -0.06 | £ -0.02 |
| Weighted Average Shares Outstanding | 5.75B | 4.77B | 3.74B | 669.84M | 642.99M |
| Weighted Average Shares Outstanding (Diluted) | 5.75B | 4.77B | 3.74B | 670.36M | 642.99M |
Currency in GBP

